Essential Drugs provider in Belgium

Aark pharmaceuticals is one of the leading Indian medicine suppliers that supply all kinds of drugs including generic drugs, non-essential and essential medicines to all over the world. Some of the major countries where Medicines are supplied by Aark pharmaceuticals include Belgium, Latin America, United Arab Emirates, Russian countries, and other parts of the world.


 The exporting of drugs from India is dealt with by Aark Pharmaceuticals. They aim to provide all the essential drugs that are needed by people all over the world. We are one of the finest drugs suppliers in Belgium from India. When we define non-essential drugs and essential drugs then it must be clear that there are plenty of drugs in the market, out of which 70% of the drugs are duplicative and therefore fall in the category of non-essential drugs.


 


There are many definitions by which one can define drugs, but according to the World Health Organization (WHO) “essential drugs are those drugs that satisfy the healthcare needs of the majority of the population; they should therefore be available at all times in adequate amounts and in appropriate dosage forms, at a price the community can afford”. 


From a large variety of drugs, the concept of essential or lifesaving drugs leads to :


Improving the quality of drugs and easy access to drugs.

Rational prescribing and use of drugs

Lowering the cost of drugs.

 


Now comes the question that in which country these drugs should be provided first, so according to the world health organization the countries that are in the developing phase require these the most.


When it comes to the supply of these essential generic drugs then the drug supplier or exporter should be trustworthy and must be selling all types of generic drugs and other non-essential and essential drugs. 

Comments

Post a Comment

Popular posts from this blog

Hertraz (Trastuzumab): Revolutionizing Breast Cancer Treatment

Image
 Hertraz (Trastuzumab): Revolutionizing Breast Cancer Treatment Introduction: Breast cancer is one of the most prevalent and life-threatening diseases affecting women worldwide. However, significant strides have been made in the field of oncology to develop targeted therapies that improve patient outcomes. Hertraz, a groundbreaking medication based on the monoclonal antibody trastuzumab, has emerged as a game-changer in the treatment of HER2-positive breast cancer. This blog explores the efficacy, benefits, and future prospects of Hertraz in revolutionizing breast cancer treatment. Understanding Hertraz: Hertraz is a therapeutic drug that harnesses the power of trastuzumab, a monoclonal antibody that specifically targets HER2-positive breast cancer cells. HER2-positive breast cancer is characterized by an overexpression of the HER2 protein, which promotes cancer cell growth. By binding to HER2 receptors, Hertraz inhibits the growth and spread of cancer cells while enhancing the effecti
Read more

Midostar-Midostaurin: A Promising Breakthrough in Cancer Treatment

Image
  Introduction: Cancer continues to be a formidable disease, affecting millions of lives worldwide. However, the field of oncology has witnessed significant advancements, leading to the development of targeted therapies that offer new hope for patients. One such breakthrough is Midostar-Midostaurin , a novel medication with immense potential in the treatment of certain types of cancers. In this blog post, we will explore the mechanism of action, clinical applications, and the future prospects of Midostar-Midostaurin. Understanding Midostar-Midostaurin: Midostar-Midostaurin belongs to a class of drugs known as kinase inhibitors. It specifically targets and inhibits certain enzymes called receptor tyrosine kinases, including FLT3 and KIT. These enzymes play a critical role in the growth and proliferation of cancer cells, particularly in acute myeloid leukemia (AML) and aggressive systemic mastocytosis (ASM). Clinical Applications: Acute Myeloid Leukemia (AML): AML is a fast-growing type
Read more

Direct to patient pharmacy

Image
 Making clinical preliminaries more tolerant-driven is among the many difficulties confronting the drug business. One technique for further developing the patient experience is by conveying concentrate taking drugs straightforwardly to patient homes, otherwise called Direct-to-Patient or DTP. Notwithstanding, the execution of Direct-to-Patient might appear to be unrealistic in a profoundly controlled industry where explicit guidelines or direction is missing or ambiguous. Moreover, Direct-to-Patient encounters can be conflicting by nation, preliminary, or helpful region.  Along these lines, in follow up to the peak blog entry, Developing a Guide for Patient-Centric Logistics - Get Involved1 a working together with a group of Direct-to-Patient Sponsors, Couriers, CROS, and QPs will, through a progression of web journals, distinguish a portion of the direct-to-patient models, share contemplations for building up a Direct-to-Patient program according to the partners' point of view and
Read more